Aytu BioScience (AYTU) Misses Q2 EPS by 4c

Aytu BioScience (NASDAQ: AYTU) reported Q2 EPS of ($0.04). Revenue for the quarter came in at $22.93 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• NVE Corporation names new CEO and expands board to seven members